Medtronic Dips: Is Now the Time to Buy?
MarketBeatMedtronic had another stable quarter with FCF growth and healthy capital returns. Analysts Hold the stock and see it advancing 15% at the midpoint.
Medtronic had another stable quarter with FCF growth and healthy capital returns. Analysts Hold the stock and see it advancing 15% at the midpoint.